Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
NCT06025045
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer Stage IV
Ovarian Cancer Stage III
Sponsor
Jing Li
Collaborators
[object Object]